RIM
Ranger Investment Management’s CONMED CNMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200,342
| Closed | -$13.7M | – | 81 |
|
|
2024
Q4 | $13.7M | Sell |
200,342
-3,865
| -2% | -$265K | 0.87% | 46 |
|
|
2024
Q3 | $14.7M | Buy |
204,207
+7,712
| +4% | +$555K | 0.94% | 42 |
|
|
2024
Q2 | $13.6M | Sell |
196,495
-2,495
| -1% | -$173K | 0.93% | 47 |
|
|
2024
Q1 | $15.9M | Sell |
198,990
-137,559
| -41% | -$11M | 1.02% | 45 |
|
|
2023
Q4 | $36.9M | Buy |
336,549
+1,675
| +0.5% | +$183K | 2.23% | 12 |
|
|
2023
Q3 | $33.8M | Sell |
334,874
-12,369
| -4% | -$1.25M | 2.24% | 12 |
|
|
2023
Q2 | $47.2M | Buy |
347,243
+10,540
| +3% | +$1.43M | 2.84% | 7 |
|
|
2023
Q1 | $35M | Buy |
336,703
+20,385
| +6% | +$2.12M | 2.34% | 18 |
|
|
2022
Q4 | $28M | Buy |
316,318
+9,676
| +3% | +$858K | 2.08% | 17 |
|
|
2022
Q3 | $24.6M | Buy |
306,642
+12,651
| +4% | +$1.01M | 1.93% | 20 |
|
|
2022
Q2 | $28.2M | Buy |
293,991
+51,016
| +21% | +$4.89M | 2.13% | 17 |
|
|
2022
Q1 | $36.1M | Buy |
242,975
+6,210
| +3% | +$922K | 2.28% | 15 |
|
|
2021
Q4 | $33.6M | Sell |
236,765
-17,024
| -7% | -$2.41M | 1.83% | 21 |
|
|
2021
Q3 | $33.2M | Sell |
253,789
-6,735
| -3% | -$881K | 1.77% | 24 |
|
|
2021
Q2 | $35.8M | Sell |
260,524
-6,065
| -2% | -$834K | 1.87% | 20 |
|
|
2021
Q1 | $34.8M | Sell |
266,589
-28,075
| -10% | -$3.67M | 1.92% | 21 |
|
|
2020
Q4 | $33M | Sell |
294,664
-10,050
| -3% | -$1.13M | 1.74% | 28 |
|
|
2020
Q3 | $24M | Buy |
304,714
+57,031
| +23% | +$4.49M | 1.53% | 29 |
|
|
2020
Q2 | $17.8M | Sell |
247,683
-58,063
| -19% | -$4.18M | 1.22% | 37 |
|
|
2020
Q1 | $17.5M | Buy |
305,746
+93,441
| +44% | +$5.35M | 1.54% | 28 |
|
|
2019
Q4 | $23.7M | Buy |
212,305
+97,562
| +85% | +$10.9M | 1.57% | 28 |
|
|
2019
Q3 | $11M | Buy |
+114,743
| New | +$11M | 0.79% | 49 |
|